Adiponectin and visfatin levels in extremely low birth weight infants; They are also at risk for insulin resistance

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 4, 2013, Pages 501-506

  Cekmez, F ^a   Canpolat, F E ^a   Pirgon, O ^b   Aydemir, G ^a   Tanju, I A ^a   Genc, F A ^a   Tunc, T ^a   Aydinoz S ^a   Yildirim, S ^c   Ipcioglu, O M ^a   Sarici, S U ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Medicana Konya Hospital   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Insulin resistance; Neonate; Visfatin

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EXTREMELY LOW BIRTH WEIGHT; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NEWBORN; OBESITY; PREMATURITY; RISK FACTOR; SMALL FOR DATE INFANT;

ADIPONECTIN; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CYTOKINES; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN; INSULIN RESISTANCE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RISK; TRIGLYCERIDES;

EID: 84878568125     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BEARDSALL K, DIDERHOLM BM, DUNGER DB. Insulin and carbohydrate metabolism. Best Pract Res Clin Endocrinol Metab 2008; 22: 41-55.
2. VAN AERDE JE, WILKE MS, FELDMAN M, et al. Accretion of lipid in the fetus and newborn. In: Polin RA, Fox WW, Abman SH, eds. Fetal and Neonatal Physiology. Vol 1. 3rd edn. Philadelphia, Pennsylvania, USA: Saunders, 2003: pp. 388-404.
3. HALL NJ, PETERS M, EATON S, PIERRO A. Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 2004; 39: 898-901.
4. HAYS SP, SMITH EO, SUNEHAG AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low bir th-weight infants. Pediatrics 2006;118: 1811-1888.
5. KAO LS, MORRIS BH, LALLY KP, STEWART CD, HUSEBY V, KENNEDY KA. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006; 26: 730-736.
6. ERTL T, GYARMATI J, GAÁL V, SZABÓ I. Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate 2006; 89: 56-59.
7. BLANCO CL, BAILLARGEON JG, MORRISON RL, GONG AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006; 26: 737-741.
8. FARRAG HM, NAWRATH LM, HEALEY JE, DORCUS EJ, RAPOZA RE, OH W, COWETT RM. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. Am J Physiol 1997; 272: E86-E93.
9. RIZZA RA, MANDARINO LJ, GERICH JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981; 240: E630-E639.
10. HALES CN, BARKER DJ, CLARK PM, COX LJ, FALL C, OSMOND C, WINTER PD. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991; 303: 1019-1022.
11. LIHN AS, PEDERSEN SB, RICHELSEN B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6: 13-21.
12. GIL-CAMPOS M, CANETE R, GIL A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004; 23: 963-974.
13. LIHN AS, PEDERSEN SB, RICHELSEN B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005; 6: 13-21.
14. WEYER C, FUNAHASHI T, TANAKA S, HOTTA K, MATSUZAWA Y, PRATLEY RE, TATARANNI PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
15. PUNTHAKEE Z, DELVIN EE, O'LOUGHLIN J, PARADIS G, LEVY E, PLATT RW, LAMBERT M. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab 2006; 91: 2119-2125.
16. GIL-CAMPOS M, CANETE R, GIL A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004; 23: 963-974.
17. FUKUHARA A, MATSUDA M, NISHIZAWA M, SEGAWA K, TANAKA M, KISHIMOTO K, MATSUKI Y, MURAKAMI M, ICHISAKA T, MURAKAMI H, WATANABE E, TAKAGI T, AKIYOSHI M, OHTSUBO T, KIHARA S, YAMASHITA S, MAKISHIMA M, FUNAHASHI T, YAMANAKA S, HIRAMATSU R, MATSUZAWA Y, SHIMOMURA I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 21: 426-430.
18. HAIDER DG, SCHALLER G, KAPIOTIS S, MAIER C, LUGER A, WOLZT M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49: 1909.
19. MERAL C, CEKMEZ F, PIRGON O, TANJU I A, IPCIOGLU OM, KARADEMIR F, GOCMEN I. The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth. J Matern Fet Neonat Med, DOI:10.3 09/14767058.2010.482604.
20. AMINI SB, CATALANO PM, HIRSCH V, MANN LI. An analysis of birth weight by gestational age using a computerized perinatal data base, 1975-1992. Obstet Gynecol 1994; 83: 342-352.
21. FENTON TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003; 3: 13.
22. MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
23. JENSEN CB, STORGAARD H, DELA F, HOLST JJ, MADSBAD S, VAAG AA. Early differential defects of insulin secretion and action in 19-year-old Caucasian men who had low birth weight. Diabetes 2002; 51: 1271-1280.
24. VAAG A. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights. Dan Med Bull 1999; 46: 197-234.
25. LEIPALA JA, RAIVIO KO, SARNESTO A, PANTELEON A, FELLMAN V. Intrauterine growth restriction and postnatal steroid treatment effects on insulin sensitivity in preterm neonates. J Pediatr 2002; 141: 472-476.
26. GRAY IP, COOPER PA, CORY BJ, TOMAN M, CROWTHER NJ. The intrauterine environment is a strong determinant of glucose tolerance during the neonatal period, even in prematurity. J Clin Endocrinol Metab 2002; 87: 4252-4256.
27. SOTO N, BAZAES RA, PENA V, SALAZAR T, AVILA A, INIGUEZ G, ONG KK, DUNGER DB, MERICQ MV. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohor t. J Clin Endocr inol Metab 2003; 88: 3645-3650.
28. DAIMON M, OIZUMI T, SAITOH T, KAMEDA W, HIRATA A, YAMAGUCHI H, OHNUMA H, IGARASHI M, TOMINAGA M, KATO T; FUNAGATA STUDY. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. The Funagata Study. Diabetes Care 2003; 26: 2015-2020.
29. MALAMITSI-PUCHNER A, DESPINA D. BRIANA, BOUTSIKOU M, KOUSKOUNI E, HASSIAKOS D, GOURGIOTIS D. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007; 6: 1314-1318.